HPR65 Prevalence as a Driver of Treatment Cost for Drugs in the Rare Disease Field in Italy

Abstract

Authors

G Casilli R Ravasio D Lidonnici M De Nigris

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×